Rime Therapeutics

“Roche signed an obesity drug licensing deal with VC-backed Chinese biotech Rona Therapeutics, including $100m upfront and up to $1.06b in earnouts.”

“$80.5M Series A, example of clinical-stage therapeutics funding. A clinical-stage biopharmaceutical company developing first-in-class therapies for kidney disease”

“R1 Therapeutics, a dialysis phosphate drug company, raised a $3M Series A.”